Page last updated: 2024-08-26

peptide elongation factor 2 and Atypical Ductal Hyperplasia

peptide elongation factor 2 has been researched along with Atypical Ductal Hyperplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braunstein, S; Connolly, E; Formenti, S; Schneider, RJ1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and Atypical Ductal Hyperplasia

ArticleYear
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.
    Molecular and cellular biology, 2006, Volume: 26, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Blotting, Western; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Cycle Proteins; Cell Line, Transformed; Cell Line, Tumor; Enzyme Activation; Female; Gene Silencing; Humans; Hypoxia; Methionine; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Precipitin Tests; Protein Kinases; Retroviridae; Ribosomal Protein S6 Kinases; RNA Interference; RNA, Small Interfering; Signal Transduction; Sulfur Radioisotopes; TOR Serine-Threonine Kinases

2006